Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims

By Reuters News

Oct 1 (Reuters) - Florida Attorney General James Uthmeier on Thursday filed a lawsuit against Pfizer PFE.N and its CEO, Albert Bourla, accusing the drugmaker of misleading consumers about the safety and effectiveness of its COVID-19 vaccine.


Here are more details:

  • Uthmeier filed the lawsuit in state court, alleging that Pfizer told consumers its COVID-19 vaccine was safe while failing to disclose potential risks, including heart inflammation and other adverse events.

  • The lawsuit says Pfizer urged people to get the shot to protect others, even though the company never tested whether the vaccine stopped the virus from spreading.

  • Florida has also accused Pfizer of using unfair tactics to dominate the market.

  • It said the company made more than $80 billion from vaccine sales, then nearly quadrupled the price of the vaccine to a range of $110 to $130 a dose in 2023 from $30.

  • The state, suing under its consumer protection law, wants a court order to stop the alleged conduct, fines of $10,000 per violation, or $15,000 when seniors or disabled people were harmed, and the return of profits.

  • Pfizer did not immediately respond to Reuters' request for comment, while the Florida Attorney General's Office did not immediately respond to a request for additional comment.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.